» Articles » PMID: 37873864

Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines

Abstract

Antibodies and other new antibody-like formats have emerged as one of the most rapidly growing classes of biotherapeutic proteins. Understanding the structural features that drive antibody function and, consequently, their molecular recognition is critical for engineering antibodies. Here, we present the structural architecture of conventional IgG antibodies alongside other formats. We emphasize the importance of considering antibodies as conformational ensembles in solution instead of focusing on single-static structures because their functions and properties are strongly governed by their dynamic nature. Thus, in this review, we provide an overview of the unique structural and dynamic characteristics of antibodies with respect to their antigen recognition, biophysical properties, and effector functions. We highlight the numerous technical advances in antibody structure prediction and design, enabled by the vast number of experimentally determined high-quality structures recorded with cryo-EM, NMR, and X-ray crystallography. Lastly, we assess antibody and vaccine design strategies in the context of structure and dynamics.

Citing Articles

Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies.

Kim H, Kim Y Appl Microsc. 2025; 55(1):1.

PMID: 39828773 PMC: 11743405. DOI: 10.1186/s42649-024-00106-y.

References
1.
Lohr T, Sormanni P, Vendruscolo M . Conformational Entropy as a Potential Liability of Computationally Designed Antibodies. Biomolecules. 2022; 12(5). PMC: 9138470. DOI: 10.3390/biom12050718. View

2.
Wu N, Wilson I . Influenza Hemagglutinin Structures and Antibody Recognition. Cold Spring Harb Perspect Med. 2019; 10(8). PMC: 7397844. DOI: 10.1101/cshperspect.a038778. View

3.
Ruffolo J, Chu L, Mahajan S, Gray J . Fast, accurate antibody structure prediction from deep learning on massive set of natural antibodies. Nat Commun. 2023; 14(1):2389. PMC: 10129313. DOI: 10.1038/s41467-023-38063-x. View

4.
De Genst E, Silence K, Decanniere K, Conrath K, Loris R, Kinne J . Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci U S A. 2006; 103(12):4586-91. PMC: 1450215. DOI: 10.1073/pnas.0505379103. View

5.
Kirkpatrick E, Qiu X, Wilson P, Bahl J, Krammer F . The influenza virus hemagglutinin head evolves faster than the stalk domain. Sci Rep. 2018; 8(1):10432. PMC: 6041311. DOI: 10.1038/s41598-018-28706-1. View